Rainmed Medical Limited (2297) Stock Statistics & Valuation Metrics

Rainmed Medical Limited has a market cap or net worth of HK$406.39M. The enterprise value is HK$339.79M.

Rainmed Medical Limited has 1,401,358,800 shares outstanding. The number of shares has decreased by -2.65% in one year.

Rainmed Medical Limited’s return on equity (ROE) is -0.28 and return on invested capital (ROIC) is -27.15%.

The current PE Ratio of Rainmed Medical Limited is ―. Rainmed Medical Limited’s PEG ratio is -1.99.

In the last 12 months, Rainmed Medical Limited had revenue of 39.82M and earned -113.50M in profits. Earnings per share was -0.10.

In the last 12 months, operating cash flow was -43.11M and capital expenditures -37.49M, giving a free cash flow of -80.60M billion.

Rainmed Medical Limited pays an annual dividend of ―, resulting in a dividend yield of ―

Rainmed Medical Limited upcoming earnings date is Mar 26, 2026, TBA (Confirmed).

Rainmed Medical Limited as a current ratio of 4.92, with Debt / Equity ratio of 8.34%

In the past 12 months, Rainmed Medical Limited has paid 242.00K in taxes.

Rainmed Medical Limited EV to EBITDA ratio is -1.85, with an EV/FCF ratio of -1.11.

Rainmed Medical Limited has HK$200.75M in cash and marketable securities with HK$33.80M in debt, giving a net cash position of HK$166.95M billion.

Gross margin is 44.22%, with operating margin of -297.04%, and net profit margin of -284.99%.

The average price target for Rainmed Medical Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―